Crucell is a biotechnology company specializing in vaccines and biopharmaceutical technologies. The firm, a subsidiary of Johnson & Johnson, is headquartered in Leiden, Netherlands. Crucell shares were previously listed on the Euronext Amsterdam exchange and formed part of the AMX index until April 2011, when J&J completed a tender offer for the company.
| Attributes | Values |
|---|---|
| rdfs:comment |
|
| foaf:name |
|
| foaf:homepage | |
| assets ($) |
|
| equity ($) |
|
| founding year |
|
| industry | |
| internationally |
|
| key person | |
| location | |
| net income ($) |
|
| number of employees |
|
| operating income ($) |
|
| owner | |
| owning company | |
| product | |
| revenue ($) |
|
| type |